Seizing control: How dense granule effector proteins enable Toxoplasma to take charge

Michael W Panas1, John C Boothroyd1

  • 1Department Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.

Molecular Microbiology
|January 5, 2021
PubMed

Insights

Toxoplasma gondii manipulates host cells using dense granule effectors to control cellular processes and immune responses. This review details effector functions and their trafficking pathways from the parasitophorous vacuole.

Area of Science:

  • * Parasitology
  • * Cell Biology
  • * Immunology

Background:

  • * Apicomplexan parasites, like *Toxoplasma gondii*, require host cell control for intracellular growth.
  • * Dense granules export effector proteins that disrupt host cell functions and immune responses.
  • * Effectors translocate to the parasitophorous vacuole, host cytoplasm, and nucleus, altering transcription.

Purpose of the Study:

  • * To review the complex mechanisms by which *Toxoplasma gondii* effectors manipulate host cell processes.
  • * To discuss recent advances in understanding dense granule effector protein trafficking.

Main Methods:

  • * This is a review article, synthesizing existing research.
  • * Analysis of published literature on *Toxoplasma gondii* effector proteins and host-parasite interactions.
  • * Examination of studies on dense granule protein secretion and localization.

Main Results:

  • * Dense granule effectors significantly alter host innate immunity, cell cycle, and organelle association.
  • * Coordinated action of multiple effectors underlies host cell manipulation.
  • * Understanding effector trafficking is key to deciphering host-parasite interactions.

Conclusions:

  • * *Toxoplasma gondii* employs a sophisticated arsenal of dense granule effectors to establish and maintain intracellular infection.
  • * Further research into effector function and trafficking pathways will illuminate parasite survival strategies.
  • * This knowledge is crucial for developing targeted anti-parasitic therapies.